Properties of Dual-Crosslinked Collagen-Based Membranes as Corneal Repair Material
Journal of Functional Biomaterials · 10.07.2023 · 14 (7) · 360
DOI: 10.3390/jfb14070360 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Functional Biomaterials, online erschienen am 10.07.2023. Verfasst von Lulu Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Henan Provincial People's Hospital, Henan Eye Hospital, Zhengzhou University People's Hospital, Zhengzhou 450003, China. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Key R&D Program of China, Guangdong Province Key Field R&D Program Projects.
Abstract (Originalsprache)
Corneal disease has become the second leading cause of blindness in the world. Corneal transplantation is currently considered to be one of the common treatments for vision loss. This paper presents a novel approach utilizing dual-crosslinked membranes composed of polyrotaxane multiple aldehydes (PRAs), 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC), and N-hydroxysuccinimide (NHS) in the development process. Collagen was crosslinked, respectively, by EDC/NHS and PRAs to form stable amide bonds and imine groups. Through the formation of a double interpenetrating network, dual-crosslinked (Col-EDC-PRA) membranes exhibited enhanced resistance to collagenase degradation and superior mechanical properties compared to membranes crosslinked with a single crosslinker. Furthermore, Col-EDC-PRA membranes display favorable light transmittance and water content characteristics. Cell experiments showed that Col-EDC-PRA membranes were noncytotoxic and were not significantly different from other membranes. In a rabbit keratoplasty model, corneal stromal repair occurred at 5 months, evidenced by the presence of stromal cells and neo-stroma, as depicted in hematoxylin–eosin-stained histologic sections and optical coherence tomography images of the anterior segment. Moreover, there was no inflammation and corneal neovascularization, as well as no corneal rejection reaction in the surgical area. Overall, the results demonstrated that the dual-crosslinked membranes served effectively for corneal tissue regeneration after corneal defect.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Henan Provincial People's Hospital, Henan Eye Hospital, Zhengzhou University People's Hospital, Zhengzhou 450003, China.
- National Engineering Research Center for Tissue Restoration and Reconstruction, Guangzhou 510006, China.
- Guangzhou Proud Seeing Biotechnology Co., Ltd., Guangzhou 510623, China.
- School of Biology and Biological Engineering, South China University of Technology, Guangzhou 510006, China.
- School of Materials Science and Engineering, South China University of Technology, Guangzhou 510006, China.
ORCID-Profile: Lulu Wang
Förderung
- National Natural Science Foundation of China
- National Key R&D Program of China
- Guangdong Province Key Field R&D Program Projects
- Guangdong Scientific and Technological Project
- Guangzhou Regenerative Medicine and Health Guangdong Laboratory
- Henan Province Key Medical Science and Technology Projects
- National Key R&D Program of China
- Guangdong Province Key Field R&D Program Projects
Zitieren
APA
Wang, L., Peng, Y., Liu, W., & Ren, L. (2023). Properties of Dual-Crosslinked Collagen-Based Membranes as Corneal Repair Material. Journal of Functional Biomaterials, 14(7), 360. https://doi.org/10.3390/jfb14070360
Vancouver
Wang L, Peng Y, Liu W, Ren L. Properties of Dual-Crosslinked Collagen-Based Membranes as Corneal Repair Material. Journal of Functional Biomaterials. 2023;14(7):360. doi:10.3390/jfb14070360
BibTeX
@article{Wang2023,
author = {Wang, Lulu and Peng, Yuehai and Liu, Wenfang and Ren, Li},
title = {Properties of Dual-Crosslinked Collagen-Based Membranes as Corneal Repair Material},
journal = {Journal of Functional Biomaterials},
year = {2023},
volume = {14},
number = {7},
pages = {360},
doi = {10.3390/jfb14070360}
}
EUVIMED